Low and Ultralow HER2 Expression in Breast Cancer is Now Detectable by Indica Labs’ Breast IHC AI

Indica Labs, the leading provider of AI-powered digital pathology solutions, announces today an upda...

U.S. Payers and CGP

TruSight Oncology Comprehensive (TSO Comprehensive) is the first U.S. FDA-approved, distributable co...

Imagene Recognized Among Top 25 Healthcare AI Companies of 2025

The Healthcare Technology Report has announced its prestigious list of The Top 25 Healthcare AI Comp...

Roche Granted FDA Breakthrough Device Designation for First AI-driven Companion Diagnostic for Non-small Cell Lung Cancer

Roche announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device D...

HistoWiz and PathologyOutlines.com Partner to Streamline Digital Slide Integration for Pathology Publications via PathologyMap™ Platform

HistoWiz, Inc., a global leader in histopathology services and digital pathology innovation, has for...

Single-Nucleus RNA-Sequencing Sheds Light on the Spatial Landscape of Glioblastoma’s Subventricular Zone

by Christos Evangelou, MSc, PhD – Medical Writer and Editor Glioblastoma (GBM) is one of the most ...